+987.9%
MRNA vs MKC
-18.2%
+1,006.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MKC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +5.4% | +7.7% | +11.8% |
| 7D | +20.6% | +9.6% | +11.0% | +18.2% |
| 30D | +27.1% | +12.0% | +15.1% | +23.0% |
| 3M | +353.4% | -2.0% | +355.4% | +376.0% |
| 6M | +446.3% | +7.2% | +439.1% | +483.2% |
| YTD | +776.2% | -23.7% | +799.9% | +753.1% |
| 1Y | +987.9% | -18.3% | +1,006.2% | +952.3% |
| All | +987.9% | -18.2% | +1,006.1% | +952.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MKC.
Daily Out/Under-Performance
Portfolio return minus MKC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MKC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MKC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling